Splenic Marginal-zone Lymphoma: One or More Entities? A Histologic, Immunohistochemical, and Molecular Study of 42 Cases

We analyzed 42 splenic marginal-zone lymphoma (SMZL) cases diagnosed on splenectomy specimens after established World Health Organization criteria. A predominantly nodular growth pattern was observed in 24 cases; the remainder showed predominantly (11/42) or exclusively (7/42) diffuse infiltration. Twenty-one cases showed the “classic” biphasic appearance; 13 cases exhibited marginal-zone morphology; finally, 8 cases were composed predominantly of small cells. CD21 and CD35 were expressed by 12/42 and 17/38 cases, respectively. DBA.44 was detected in 24/42 cases. Seventeen of 37 cases were surface IgD (SIgD)-positive. Twenty-one of 22 analyzed cases were SIgM-positive (12/21 coexpressed SIgD). Five of 37 cases were SIgG-positive. CD27 staining was observed in 21/35 cases; 7/18 CD27-positive cases coexpressed SIgD; 7/14 CD27-negative cases were SIgD-positive. Forty IGHV-D-J rearrangements were amplified in 34/42 cases: the IGHV4-34 gene predominated, followed by IGHV1-2. Using the 98% homology cut-off, 25/40 (62.5%) IGHV sequences were considered as “mutated”: 10/11 cases with monomorphous, marginal-zone morphology were IGHV-mutated; in contrast, 4/6 cases with monomorphous, small-cell morphology were IGHV-unmutated. Five of 7 cases expressing IGHV1 subgroup genes had biphasic morphology, whereas 6/9 IGHV3-expressing cases had monomorphous, marginal-zone morphology. Most IGHV-mutated cases (14/20; 70%) were SIgD-negative; in contrast, 8/11 IGHV-unmutated cases expressed SIgD. CD27 was detected in 10/17 IGHV-mutated and 6/10 IGHV-unmutated cases. Seven of 11 CD27-negative cases were IGHV-mutated; 5/7 CD27-negative/IGHV-mutated cases expressed DBA.44. These results confirm the considerable histologic, immunohistochemical, and molecular heterogeneity of SMZL and indicate an origin from the diverse resident B-cell populations of the normal SMZ.

[1]  Jérôme Lane,et al.  IMGT®, the international ImMunoGeneTics information system® , 2004, Nucleic Acids Res..

[2]  L. Staudt,et al.  Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. , 2004, Blood.

[3]  K. Stamatopoulos,et al.  Immunoglobulin light chain repertoire in chronic lymphocytic leukemia. , 2004, Blood.

[4]  J. Gribben,et al.  Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. , 2004, Blood.

[5]  Steven L. Allen,et al.  Multiple Distinct Sets of Stereotyped Antigen Receptors Indicate a Role for Antigen in Promoting Chronic Lymphocytic Leukemia , 2004, The Journal of experimental medicine.

[6]  K. Stamatopoulos,et al.  Immunoglobulin Heavy- And Light-chain Repertoire in Splenic Marginal Zone Lymphoma , 2004, Molecular medicine.

[7]  Marie-Paule Lefranc,et al.  IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor VJ and VDJrearrangement analysis , 2004, Nucleic Acids Res..

[8]  S. Pillai,et al.  Positive selection and lineage commitment during peripheral B‐lymphocyte development , 2004, Immunological reviews.

[9]  K. Toellner,et al.  Extrafollicular antibody responses , 2003, Immunological reviews.

[10]  Thomas Boehm,et al.  Human Immunoglobulin M Memory B Cells Controlling Streptococcus pneumoniae Infections Are Generated in the Spleen , 2003, The Journal of experimental medicine.

[11]  G. Gaidano,et al.  The Human Marginal Zone B Cell , 2003, Annals of the New York Academy of Sciences.

[12]  J. Delabie,et al.  Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations. , 2003, The American journal of pathology.

[13]  B. Sutton,et al.  Evidence for Involvement of a Hydrophobic Patch in Framework Region 1 of Human V4-34-Encoded Igs in Recognition of the Red Blood Cell I Antigen1 , 2002, The Journal of Immunology.

[14]  W. Timens,et al.  The dual function of the splenic marginal zone: essential for initiation of anti‐TI‐2 responses but also vital in the general first‐line defense against blood‐borne antigens , 2002, Clinical and experimental immunology.

[15]  D. Oscier,et al.  V(H) gene analysis of splenic marginal zone lymphomas reveals diversity in mutational status and initiation of somatic mutation in vivo. , 2002, Blood.

[16]  X. Mariette,et al.  Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. , 2002, The New England journal of medicine.

[17]  S. Swerdlow,et al.  Splenic marginal zone lymphomas appear to originate from different B cell types. , 2002, The American journal of pathology.

[18]  J. Kearney,et al.  Marginal-zone B cells , 2002, Nature Reviews Immunology.

[19]  E. Campo,et al.  Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. , 2002, Blood.

[20]  K. Toellner,et al.  Low-level Hypermutation in T Cell–independent Germinal Centers Compared with High Mutation Rates Associated with T Cell–dependent Germinal Centers , 2002, The Journal of experimental medicine.

[21]  C. Wolf‐peeters,et al.  Marginal zone cell lymphoma—an update on recent advances , 2002, Histopathology.

[22]  R. Brezinschek,et al.  The role of CD40-CD40 ligand (CD154) interactions in immunoglobulin light chain repertoire generation and somatic mutation. , 2001, Clinical immunology.

[23]  S. Pillai,et al.  The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. , 2001, Immunity.

[24]  M. Piris,et al.  Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5′ non-coding region of the bcl-6 gene , 2001, Leukemia.

[25]  F. Deist,et al.  CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  G. Widhopf,et al.  Normal B Cells Express 51p1-Encoded Ig Heavy Chains That Are Distinct From Those Expressed by Chronic Lymphocytic Leukemia B Cells1 , 2001, The Journal of Immunology.

[27]  T. Molina,et al.  Splenic Marginal Zone Lymphoma With or Without Plasmacytic Differentiation , 2000, The American journal of surgical pathology.

[28]  N. Chiorazzi,et al.  Heterogeneity of Tonsillar Subepithelial B Lymphocytes, the Splenic Marginal Zone Equivalents1 , 2000, The Journal of Immunology.

[29]  A. Lustig,et al.  Autoreactive B Cells Escape Clonal Deletion by Expressing Multiple Antigen Receptors1 , 2000, The Journal of Immunology.

[30]  V. Kouskoff,et al.  T cell-independent rescue of B lymphocytes from peripheral immune tolerance. , 2000, Science.

[31]  G Flandrin,et al.  The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[32]  P. Isaacson,et al.  Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutation. , 1998, Human pathology.

[33]  P. Isaacson,et al.  Splenic marginal zone lymphoma. , 1997, Seminars in diagnostic pathology.

[34]  T. Kipps,et al.  The V4-34 encoded anti-i autoantibodies recognize a large subset of human and mouse B-cells. , 1996, Blood cells, molecules & diseases.

[35]  P. Isaacson.  Splenic marginal zone lymphoma [letter; comment] , 1996 .

[36]  P. Isaacson.  Splenic marginal zone lymphoma. , 1996, Blood.

[37]  J. Greer,et al.  Splenic marginal zone lymphoma. A distinct B-cell neoplasm. , 1996, The American journal of surgical pathology.

[38]  C. D. Wu,et al.  Splenic marginal zone cell lymphoma. An immunophenotypic and molecular study of five cases. , 1996, American journal of clinical pathology.

[39]  S. Pittaluga,et al.  "Small" B-cell non-Hodgkin's lymphomas with splenomegaly at presentation are either mantle cell lymphoma or marginal zone cell lymphoma. A study based on histology, cytology, immunohistochemistry, and cytogenetic analysis. , 1996, The American journal of surgical pathology.

[40]  E. Campo,et al.  Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases. , 1995, The American journal of surgical pathology.

[41]  P. Isaacson,et al.  Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells , 1995, The Journal of experimental medicine.

[42]  D. Oscier,et al.  Splenic lymphoma with villous lymphocytes involves B cells with extensively mutated Ig heavy chain variable region genes. , 1995, Blood.

[43]  D. Catovsky,et al.  The histopathology of splenic lymphoma with villous lymphocytes. , 1994, Blood.

[44]  P. Isaacson,et al.  Splenic Marginal Zone Cell Lymphoma , 1992, The American journal of surgical pathology.

[45]  S. Pillai,et al.  Marginal zone B cells. , 2005, Annual review of immunology.

[46]  M. Dono,et al.  Immunoglobulin gene mutation patterns and heterogeneity of marginal zone lymphoma. , 2005, Methods in molecular medicine.

[47]  L. McHeyzer-Williams,et al.  Antigen-specific memory B cell development. , 2005, Annual review of immunology.

[48]  M. Paulli,et al.  Marginal zone-related neoplasms of splenic and nodal origin. , 2003, Haematologica.

[49]  M. Lefranc,et al.  IMGT® databases, web resources and tools for immunoglobulin and T cell receptor sequence analysis, http://imgt.cines.fr , 2003, Leukemia.

[50]  J. Climent,et al.  Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q. , 2001, Haematologica.

[51]  J. Delabie,et al.  Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion. , 1999, Blood.

[52]  M. Paulli,et al.  Splenic marginal zone cell lymphoma: report of an indolent variant without massive splenomegaly presumably representing an early phase of the disease. , 1995, Human pathology.

[53]  A. Scarpa,et al.  A CD5+ leukemic lymphoma with monocytoid features: an unusual B-cell lymphoma mimicking hairy-cell leukemia. , 1993, Acta haematologica.